WO1998050576A8 - Betaines as adjuvants to susceptibility testing and antimicrobial therapy - Google Patents

Betaines as adjuvants to susceptibility testing and antimicrobial therapy

Info

Publication number
WO1998050576A8
WO1998050576A8 PCT/US1998/008760 US9808760W WO9850576A8 WO 1998050576 A8 WO1998050576 A8 WO 1998050576A8 US 9808760 W US9808760 W US 9808760W WO 9850576 A8 WO9850576 A8 WO 9850576A8
Authority
WO
WIPO (PCT)
Prior art keywords
betaines
adjuvants
susceptibility testing
antimicrobial therapy
susceptibility
Prior art date
Application number
PCT/US1998/008760
Other languages
French (fr)
Other versions
WO1998050576A1 (en
Inventor
Charles G Thornton
Original Assignee
Integrated Research Technology
Charles G Thornton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integrated Research Technology, Charles G Thornton filed Critical Integrated Research Technology
Priority to EP98920928A priority Critical patent/EP0980438A4/en
Priority to CA002288457A priority patent/CA2288457A1/en
Priority to AU73652/98A priority patent/AU7365298A/en
Priority to EA199901001A priority patent/EA002808B1/en
Priority to JP54821498A priority patent/JP2001523970A/en
Publication of WO1998050576A1 publication Critical patent/WO1998050576A1/en
Publication of WO1998050576A8 publication Critical patent/WO1998050576A8/en
Priority to US09/429,614 priority patent/US6406880B1/en
Priority to US10/125,647 priority patent/US7067500B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is related to method and compositions for susceptibility testing of bacteria containing mycolic acid structures using betaine-like detergents, and inducing the susceptibility of such bacteria using the same.
PCT/US1998/008760 1997-05-02 1998-05-01 Betaines as adjuvants to susceptibility testing and antimicrobial therapy WO1998050576A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP98920928A EP0980438A4 (en) 1997-05-02 1998-05-01 Betaines as adjudvants to susceptibility testing and antimicrobial therapy
CA002288457A CA2288457A1 (en) 1997-05-02 1998-05-01 Betaines as adjuvants to susceptibility testing and antimicrobial therapy
AU73652/98A AU7365298A (en) 1997-05-02 1998-05-01 Betaines as adjudvants to susceptibility testing and antimicrobial thera py
EA199901001A EA002808B1 (en) 1997-05-02 1998-05-01 Betaines as adjuvants to susceptibility testing and antimicrobial therapy
JP54821498A JP2001523970A (en) 1997-05-02 1998-05-01 Betaine as an adjuvant for susceptibility testing and antimicrobial treatment
US09/429,614 US6406880B1 (en) 1997-05-02 1999-10-29 Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US10/125,647 US7067500B2 (en) 1997-05-02 2002-04-19 Betaines as adjuvants to susceptibility testing and antimicrobial therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4551297P 1997-05-02 1997-05-02
US60/045,512 1997-05-02

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/429,614 Continuation US6406880B1 (en) 1997-05-02 1999-10-29 Betaines as adjuvants to susceptibility testing and antimicrobial therapy

Publications (2)

Publication Number Publication Date
WO1998050576A1 WO1998050576A1 (en) 1998-11-12
WO1998050576A8 true WO1998050576A8 (en) 1999-10-28

Family

ID=21938324

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/008760 WO1998050576A1 (en) 1997-05-02 1998-05-01 Betaines as adjuvants to susceptibility testing and antimicrobial therapy

Country Status (7)

Country Link
EP (1) EP0980438A4 (en)
JP (1) JP2001523970A (en)
CN (1) CN1264430A (en)
AU (1) AU7365298A (en)
CA (1) CA2288457A1 (en)
EA (1) EA002808B1 (en)
WO (1) WO1998050576A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406880B1 (en) 1997-05-02 2002-06-18 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US7067500B2 (en) 1997-05-02 2006-06-27 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
AU5179800A (en) * 1999-06-03 2000-12-28 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Mycolactone and related compounds, compositions and methods of use
US6680055B1 (en) 1999-06-03 2004-01-20 The United States Of America As Represented By The Department Of Health And Human Services Mycolactone and related compounds, compositions and methods of use
FR2849204B1 (en) 2002-12-20 2005-02-11 Afssa METHOD OF DETECTING PRPSC USING AMINOGLYCOSIDE FAMILY D Antibiotics for PRPSC Removal and Detection in Biological Samples
JP2019515007A (en) * 2016-05-13 2019-06-06 スペロ ポテンシエーター インコーポレイテッドＳｐｅｒｏ Ｐｏｔｅｎｔｉａｔｏｒ， Ｉｎｃ． Enhancement of antibiotic activity by novel cationic peptide SPR 741
AU2019301054A1 (en) * 2018-07-11 2021-02-04 SeLux Diagnostics, Inc. Assays and reagents for antimicrobial susceptibility testing
CN116272921B (en) * 2023-02-15 2024-05-17 青岛盛瀚色谱技术有限公司 Monodisperse weakly acidic cation chromatographic packing and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937655A (en) * 1974-04-16 1976-02-10 Eli Lilly And Company Method for preparing stable β-lactam-type-antibiotic susceptibility test discs
US4075350A (en) * 1975-12-18 1978-02-21 Michaels Edwin B Antimicrobial compositions employing certain betaines and certain amine oxides
DE3327839A1 (en) * 1983-08-02 1985-02-14 Merck Patent Gmbh, 6100 Darmstadt METHOD AND MEANS FOR SENSITIVITY TESTING OF BACTERIA
NZ275205A (en) * 1993-09-22 1998-03-25 Xoma Corp Use of bactericidal/permeability-increasing protein in treating gram-negative bacterial infection
US5399558A (en) * 1993-11-24 1995-03-21 Pathogenesis Corporation Isoflavonoid antibacterial compounds, compositions and use
US5610198A (en) * 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
US5658749A (en) * 1994-04-05 1997-08-19 Corning Clinical Laboratories, Inc. Method for processing mycobacteria

Also Published As

Publication number Publication date
EP0980438A4 (en) 2004-10-27
AU7365298A (en) 1998-11-27
JP2001523970A (en) 2001-11-27
EA002808B1 (en) 2002-10-31
CN1264430A (en) 2000-08-23
CA2288457A1 (en) 1998-11-12
WO1998050576A1 (en) 1998-11-12
EA199901001A1 (en) 2000-06-26
EP0980438A1 (en) 2000-02-23

Similar Documents

Publication Publication Date Title
CA2338600A1 (en) Novel thiazolopyrimidine compounds
DK0741694T3 (en) Phenylacetic acid derivatives, processes and intermediates for their preparation and agents containing them
DK0760848T3 (en) Lactobacillus strains of human origin, their compositions and their use
AU2002359522A1 (en) Compositions and methods of selective nucleic acid isolation
BR9908280A (en) Phospholipase enzyme inhibitors
HK1028568A1 (en) Alpha-ketoamide multicatalytic protease inhibitors
NO954342L (en) Erythropoietin analog mixtures, as well as processes for their preparation
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
MY111201A (en) New imidazopyridines
DK0705100T3 (en) Therapeutically substituted guanidines
EP0656070A4 (en) Nucleic acid probes for bacteria of the genus legionella.
DK0994115T3 (en) Process for the preparation of pyrazolo (4,3-d) pyrimidin-7-ones and intermediates thereof
WO1998050576A8 (en) Betaines as adjuvants to susceptibility testing and antimicrobial therapy
AU4797596A (en) Use of hydrofluoroalkenes as cleaning agents, and compositions which may be used for their purpose
AU5901490A (en) Hemoregulatory peptides
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
BG100248A (en) Squalene synthetase inhibitors
CA2136841A1 (en) Novel Piperidyl Amides, Sulfonamides and Sulfoxamides as Inhibitors of Cholesterol Biosynthesis
ATE315092T1 (en) PLATELE ACTIVATE FACTOR ACETYL HYDROLASE AND CORRESPONDING GENE
AU8898198A (en) Methods of identifying biological agent compositions
WO2003055440A8 (en) Compositions and methods for the treatement of immune related diseases
DK0471252T3 (en) N-Alkyl-N- (meth) acryloyloxyalkylcarboxamides of aromatic carboxylic acids and of aromatic carboxylic anhydrides and adhesives containing these compounds
AU4450489A (en) The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
BG104452A (en) New derivatives of the methylenebisphosphonic acid

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 98805996.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 45/98 UNDER (54) THE TITLE IN ENGLISH SHOULD READ "BETAINES AS ADJUVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY"

ENP Entry into the national phase in:

Ref document number: 2288457

Country of ref document: CA

Ref document number: 2288457

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09429614

Country of ref document: US

ENP Entry into the national phase in:

Ref document number: 1998 548214

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1998920928

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 199901001

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1998920928

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1998920928

Country of ref document: EP